Infection control measures to limit the spread of Clostridium difficile

Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2008-05, Vol.14 (s5), p.2-20
Hauptverfasser: Vonberg, R.-P., Kuijper, E.J., Wilcox, M.H., Barbut, F., Tüll, P., Gastmeier, P., van den Broek, P.J., Colville, A., Coignard, B., Daha, T., Debast, S., Duerden, B.I., van den Hof, S., van der Kooi, T., Maarleveld, H.J.H., Nagy, E., Notermans, D.W., O'Driscoll, J., Patel, B., Stone, S., Wiuff, C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20
container_issue s5
container_start_page 2
container_title Clinical microbiology and infection
container_volume 14
creator Vonberg, R.-P.
Kuijper, E.J.
Wilcox, M.H.
Barbut, F.
Tüll, P.
Gastmeier, P.
van den Broek, P.J.
Colville, A.
Coignard, B.
Daha, T.
Debast, S.
Duerden, B.I.
van den Hof, S.
van der Kooi, T.
Maarleveld, H.J.H.
Nagy, E.
Notermans, D.W.
O'Driscoll, J.
Patel, B.
Stone, S.
Wiuff, C.
description Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.
doi_str_mv 10.1111/j.1469-0691.2008.01992.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69101591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14606662</els_id><sourcerecordid>1560117186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5402-8370d750667faceb349f93dfa09a9e7ec0a9fa4ac56adbea9c2d44d73153647d3</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhS0EoqXwF5BPiEtST-zE8YEDrKBUWsQFJG6W1x4Lr5J4sZPS_nuc7oreKHOZkfy9sf0eIRRYDaUu9zWITlWsU1A3jPU1A6Wa-vYJOf978LTMoPpKCv7jjLzIec8YazgXz8kZ9AIaCeycXF1PHu0c4kRtnOYUBzqiyUvCTOdIhzCGmc4_keZDQuNo9HQzxDyn4MIyUhe8DzYM-JI882bI-OrUL8j3Tx-_bT5X269X15v328q2gjVVzyVzsmVdJ72xuONCecWdN0wZhRItM8obYWzbGbdDo2zjhHCSQ8s7IR2_IG-Oew8p_lowz3oM2eIwmAnjknX5OINWwaNgUzzi6h58-08Q2o4BSOi7gvZH1KaYc0KvDymMJt1pYHoNRu_16r9e_ddrMPo-GH1bpK9Ptyy7Ed2D8JREAd4dgd_Fzbv_Xqw32y_rVPQfjnos7t8ETDrbgJNFF1IJWLsYHn_lH-KAsVo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560117186</pqid></control><display><type>article</type><title>Infection control measures to limit the spread of Clostridium difficile</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Vonberg, R.-P. ; Kuijper, E.J. ; Wilcox, M.H. ; Barbut, F. ; Tüll, P. ; Gastmeier, P. ; van den Broek, P.J. ; Colville, A. ; Coignard, B. ; Daha, T. ; Debast, S. ; Duerden, B.I. ; van den Hof, S. ; van der Kooi, T. ; Maarleveld, H.J.H. ; Nagy, E. ; Notermans, D.W. ; O'Driscoll, J. ; Patel, B. ; Stone, S. ; Wiuff, C.</creator><creatorcontrib>Vonberg, R.-P. ; Kuijper, E.J. ; Wilcox, M.H. ; Barbut, F. ; Tüll, P. ; Gastmeier, P. ; van den Broek, P.J. ; Colville, A. ; Coignard, B. ; Daha, T. ; Debast, S. ; Duerden, B.I. ; van den Hof, S. ; van der Kooi, T. ; Maarleveld, H.J.H. ; Nagy, E. ; Notermans, D.W. ; O'Driscoll, J. ; Patel, B. ; Stone, S. ; Wiuff, C. ; on behalf of the European C. difficile-Infection Control Group and the European Centre for Disease Prevention and Control (ECDC) ; European Centre for Disease Prevention and Control (ECDC) ; European C difficile-Infection Control Group</creatorcontrib><description>Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2008.01992.x</identifier><identifier>PMID: 18412710</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Clostridium ; Clostridium difficile ; Clostridium difficile - growth &amp; development ; Cross Infection - microbiology ; Cross Infection - prevention &amp; control ; Diarrhea - microbiology ; Diarrhea - prevention &amp; control ; Enterocolitis, Pseudomembranous - microbiology ; Enterocolitis, Pseudomembranous - prevention &amp; control ; evidence-based guidelines ; Evidence-Based Medicine ; Guidelines as Topic ; Humans ; Infection Control - methods ; infection control measures</subject><ispartof>Clinical microbiology and infection, 2008-05, Vol.14 (s5), p.2-20</ispartof><rights>2008 European Society of Clinical Infectious Diseases</rights><rights>2008 The Authors. Journal Compilation European Society of Clinical Microbiology and Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5402-8370d750667faceb349f93dfa09a9e7ec0a9fa4ac56adbea9c2d44d73153647d3</citedby><cites>FETCH-LOGICAL-c5402-8370d750667faceb349f93dfa09a9e7ec0a9fa4ac56adbea9c2d44d73153647d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1469-0691.2008.01992.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1469-0691.2008.01992.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18412710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vonberg, R.-P.</creatorcontrib><creatorcontrib>Kuijper, E.J.</creatorcontrib><creatorcontrib>Wilcox, M.H.</creatorcontrib><creatorcontrib>Barbut, F.</creatorcontrib><creatorcontrib>Tüll, P.</creatorcontrib><creatorcontrib>Gastmeier, P.</creatorcontrib><creatorcontrib>van den Broek, P.J.</creatorcontrib><creatorcontrib>Colville, A.</creatorcontrib><creatorcontrib>Coignard, B.</creatorcontrib><creatorcontrib>Daha, T.</creatorcontrib><creatorcontrib>Debast, S.</creatorcontrib><creatorcontrib>Duerden, B.I.</creatorcontrib><creatorcontrib>van den Hof, S.</creatorcontrib><creatorcontrib>van der Kooi, T.</creatorcontrib><creatorcontrib>Maarleveld, H.J.H.</creatorcontrib><creatorcontrib>Nagy, E.</creatorcontrib><creatorcontrib>Notermans, D.W.</creatorcontrib><creatorcontrib>O'Driscoll, J.</creatorcontrib><creatorcontrib>Patel, B.</creatorcontrib><creatorcontrib>Stone, S.</creatorcontrib><creatorcontrib>Wiuff, C.</creatorcontrib><creatorcontrib>on behalf of the European C. difficile-Infection Control Group and the European Centre for Disease Prevention and Control (ECDC)</creatorcontrib><creatorcontrib>European Centre for Disease Prevention and Control (ECDC)</creatorcontrib><creatorcontrib>European C difficile-Infection Control Group</creatorcontrib><title>Infection control measures to limit the spread of Clostridium difficile</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.</description><subject>Clostridium</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - growth &amp; development</subject><subject>Cross Infection - microbiology</subject><subject>Cross Infection - prevention &amp; control</subject><subject>Diarrhea - microbiology</subject><subject>Diarrhea - prevention &amp; control</subject><subject>Enterocolitis, Pseudomembranous - microbiology</subject><subject>Enterocolitis, Pseudomembranous - prevention &amp; control</subject><subject>evidence-based guidelines</subject><subject>Evidence-Based Medicine</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Infection Control - methods</subject><subject>infection control measures</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFv1DAQhS0EoqXwF5BPiEtST-zE8YEDrKBUWsQFJG6W1x4Lr5J4sZPS_nuc7oreKHOZkfy9sf0eIRRYDaUu9zWITlWsU1A3jPU1A6Wa-vYJOf978LTMoPpKCv7jjLzIec8YazgXz8kZ9AIaCeycXF1PHu0c4kRtnOYUBzqiyUvCTOdIhzCGmc4_keZDQuNo9HQzxDyn4MIyUhe8DzYM-JI882bI-OrUL8j3Tx-_bT5X269X15v328q2gjVVzyVzsmVdJ72xuONCecWdN0wZhRItM8obYWzbGbdDo2zjhHCSQ8s7IR2_IG-Oew8p_lowz3oM2eIwmAnjknX5OINWwaNgUzzi6h58-08Q2o4BSOi7gvZH1KaYc0KvDymMJt1pYHoNRu_16r9e_ddrMPo-GH1bpK9Ptyy7Ed2D8JREAd4dgd_Fzbv_Xqw32y_rVPQfjnos7t8ETDrbgJNFF1IJWLsYHn_lH-KAsVo</recordid><startdate>200805</startdate><enddate>200805</enddate><creator>Vonberg, R.-P.</creator><creator>Kuijper, E.J.</creator><creator>Wilcox, M.H.</creator><creator>Barbut, F.</creator><creator>Tüll, P.</creator><creator>Gastmeier, P.</creator><creator>van den Broek, P.J.</creator><creator>Colville, A.</creator><creator>Coignard, B.</creator><creator>Daha, T.</creator><creator>Debast, S.</creator><creator>Duerden, B.I.</creator><creator>van den Hof, S.</creator><creator>van der Kooi, T.</creator><creator>Maarleveld, H.J.H.</creator><creator>Nagy, E.</creator><creator>Notermans, D.W.</creator><creator>O'Driscoll, J.</creator><creator>Patel, B.</creator><creator>Stone, S.</creator><creator>Wiuff, C.</creator><general>Elsevier Ltd</general><general>Blackwell Publishing Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200805</creationdate><title>Infection control measures to limit the spread of Clostridium difficile</title><author>Vonberg, R.-P. ; Kuijper, E.J. ; Wilcox, M.H. ; Barbut, F. ; Tüll, P. ; Gastmeier, P. ; van den Broek, P.J. ; Colville, A. ; Coignard, B. ; Daha, T. ; Debast, S. ; Duerden, B.I. ; van den Hof, S. ; van der Kooi, T. ; Maarleveld, H.J.H. ; Nagy, E. ; Notermans, D.W. ; O'Driscoll, J. ; Patel, B. ; Stone, S. ; Wiuff, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5402-8370d750667faceb349f93dfa09a9e7ec0a9fa4ac56adbea9c2d44d73153647d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Clostridium</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - growth &amp; development</topic><topic>Cross Infection - microbiology</topic><topic>Cross Infection - prevention &amp; control</topic><topic>Diarrhea - microbiology</topic><topic>Diarrhea - prevention &amp; control</topic><topic>Enterocolitis, Pseudomembranous - microbiology</topic><topic>Enterocolitis, Pseudomembranous - prevention &amp; control</topic><topic>evidence-based guidelines</topic><topic>Evidence-Based Medicine</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Infection Control - methods</topic><topic>infection control measures</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vonberg, R.-P.</creatorcontrib><creatorcontrib>Kuijper, E.J.</creatorcontrib><creatorcontrib>Wilcox, M.H.</creatorcontrib><creatorcontrib>Barbut, F.</creatorcontrib><creatorcontrib>Tüll, P.</creatorcontrib><creatorcontrib>Gastmeier, P.</creatorcontrib><creatorcontrib>van den Broek, P.J.</creatorcontrib><creatorcontrib>Colville, A.</creatorcontrib><creatorcontrib>Coignard, B.</creatorcontrib><creatorcontrib>Daha, T.</creatorcontrib><creatorcontrib>Debast, S.</creatorcontrib><creatorcontrib>Duerden, B.I.</creatorcontrib><creatorcontrib>van den Hof, S.</creatorcontrib><creatorcontrib>van der Kooi, T.</creatorcontrib><creatorcontrib>Maarleveld, H.J.H.</creatorcontrib><creatorcontrib>Nagy, E.</creatorcontrib><creatorcontrib>Notermans, D.W.</creatorcontrib><creatorcontrib>O'Driscoll, J.</creatorcontrib><creatorcontrib>Patel, B.</creatorcontrib><creatorcontrib>Stone, S.</creatorcontrib><creatorcontrib>Wiuff, C.</creatorcontrib><creatorcontrib>on behalf of the European C. difficile-Infection Control Group and the European Centre for Disease Prevention and Control (ECDC)</creatorcontrib><creatorcontrib>European Centre for Disease Prevention and Control (ECDC)</creatorcontrib><creatorcontrib>European C difficile-Infection Control Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vonberg, R.-P.</au><au>Kuijper, E.J.</au><au>Wilcox, M.H.</au><au>Barbut, F.</au><au>Tüll, P.</au><au>Gastmeier, P.</au><au>van den Broek, P.J.</au><au>Colville, A.</au><au>Coignard, B.</au><au>Daha, T.</au><au>Debast, S.</au><au>Duerden, B.I.</au><au>van den Hof, S.</au><au>van der Kooi, T.</au><au>Maarleveld, H.J.H.</au><au>Nagy, E.</au><au>Notermans, D.W.</au><au>O'Driscoll, J.</au><au>Patel, B.</au><au>Stone, S.</au><au>Wiuff, C.</au><aucorp>on behalf of the European C. difficile-Infection Control Group and the European Centre for Disease Prevention and Control (ECDC)</aucorp><aucorp>European Centre for Disease Prevention and Control (ECDC)</aucorp><aucorp>European C difficile-Infection Control Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infection control measures to limit the spread of Clostridium difficile</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2008-05</date><risdate>2008</risdate><volume>14</volume><issue>s5</issue><spage>2</spage><epage>20</epage><pages>2-20</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>18412710</pmid><doi>10.1111/j.1469-0691.2008.01992.x</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2008-05, Vol.14 (s5), p.2-20
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_69101591
source MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Clostridium
Clostridium difficile
Clostridium difficile - growth & development
Cross Infection - microbiology
Cross Infection - prevention & control
Diarrhea - microbiology
Diarrhea - prevention & control
Enterocolitis, Pseudomembranous - microbiology
Enterocolitis, Pseudomembranous - prevention & control
evidence-based guidelines
Evidence-Based Medicine
Guidelines as Topic
Humans
Infection Control - methods
infection control measures
title Infection control measures to limit the spread of Clostridium difficile
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A45%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infection%20control%20measures%20to%20limit%20the%20spread%20of%20Clostridium%20difficile&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Vonberg,%20R.-P.&rft.aucorp=on%20behalf%20of%20the%20European%20C.%20difficile-Infection%20Control%20Group%20and%20the%20European%20Centre%20for%20Disease%20Prevention%20and%20Control%20(ECDC)&rft.date=2008-05&rft.volume=14&rft.issue=s5&rft.spage=2&rft.epage=20&rft.pages=2-20&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2008.01992.x&rft_dat=%3Cproquest_cross%3E1560117186%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1560117186&rft_id=info:pmid/18412710&rft_els_id=S1198743X14606662&rfr_iscdi=true